Basic Information
Pi Therapeutics is a discovery-stage biopharmaceutical company dedicated to developing a new type of anticancer drug. The company's mission is to develop novel first-in-class drugs targeting the ubiquitin-proteasome system (UPS), primarily for cancer treatment.